GKIM
HZNP

GW&K Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

GW&K Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-177
Closed -$21K – 963
2023
Q3 		$21K Sell
177
-74
-29% -$7.95K ﹤0.01% 485
2023
Q2 		$26K Sell
251
-312
-55% -$32.9K ﹤0.01% 448
2023
Q1 		$62K Sell
563
-878,765
-100% -$97.1M ﹤0.01% 345
2022
Q4 		$100M Sell
879,328
-10,024
-1% -$833K 1.01% 9
2022
Q3 		$55M Buy
889,352
+98,534
+12% +$6.88M 0.61% 48
2022
Q2 		$63.1M Sell
790,818
-84,855
-10% -$8.04M 0.68% 29
2022
Q1 		$92.1M Buy
875,673
+46,748
+6% +$4.56M 0.82% 20
2021
Q4 		$89.3M Buy
828,925
+42,129
+5% +$4.6M 0.75% 30
2021
Q3 		$86.2M Sell
786,796
-9,011
-1% -$935K 0.77% 28
2021
Q2 		$74.5M Buy
795,807
+12,436
+2% +$1.14M 0.65% 38
2021
Q1 		$72.1M Buy
783,371
+238,786
+44% +$20.2M 0.66% 33
2020
Q4 		$39.8M Buy
544,585
+438,670
+414% +$32.6M 0.42% 91
2020
Q3 		$8.23M Sell
105,915
-45,781
-30% -$3.15M 0.11% 221
2020
Q2 		$8.43M Sell
151,696
-32,633
-18% -$1.4M 0.12% 214
2020
Q1 		$5.46M Sell
184,329
-10,399
-5% -$352K 0.1% 212
2019
Q4 		$7.05M Buy
+194,728
New +$5.97M 0.09% 220

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

GW&K Investment Management's HZNP Position: Q4 2023 in Review

GW&K Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 177 shares — an estimated $21K sold.

GW&K Investment Management first reported a position in HZNP in Q4 2019 and held it in 16 quarters. The position peaked at $100M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • GW&K Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • GW&K Investment Management sold 177 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $21K.
  • GW&K Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2019 and held it in 16 quarters.
  • GW&K Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $100M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on GW&K Investment Management's 13F filing for Q4 2023, filed 9 Feb 2024.